Withdrawal of low-dose prednisone in inactive SLE patients: Is there another alternative?

Ann Rheum Dis. 2022 Apr;81(4):e57. doi: 10.1136/annrheumdis-2020-217575. Epub 2020 Apr 27.
No abstract available

Keywords: autoimmune diseases; glucocorticoids; immune system diseases.

Publication types

  • Letter
  • Comment

MeSH terms

  • Glucocorticoids* / adverse effects
  • Humans
  • Lupus Erythematosus, Systemic* / chemically induced
  • Lupus Erythematosus, Systemic* / drug therapy
  • Prednisone / adverse effects
  • Severity of Illness Index

Substances

  • Glucocorticoids
  • Prednisone